Patents by Inventor Qianqian SHAN

Qianqian SHAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240034792
    Abstract: Provided are an antigen binding protein capable of binding to PD-1 and a fusion protein thereof, and corresponding preparation method therefor and the use thereof. The fusion protein is capable of targeting PD-1 and CD73.
    Type: Application
    Filed: July 15, 2021
    Publication date: February 1, 2024
    Inventors: Haishan LUO, Qianqian SHAN, Yongqiang WANG, Xuekun ZHANG, Lei SHI, Yun ZHANG, Chuchu ZHAO, Wei ZHOU, Xin GAN
  • Publication number: 20230357425
    Abstract: Provided an isolated antigen binding protein having one or more of the following properties: a. capable of binding to both human CD73 and Cynomolgus monkey CD73; b. capable of inhibiting 5?ectonucleotidase activity of CD73; c. capable of mediating CD73 internalization; d. capable of promoting T cell proliferation; e. with a relatively stable concentration in serum; and f. capable of inhibiting tumor growth and/or tumor cell proliferation. In addition, provided a method for producing the isolated antigen binding protein as well as pharmaceutical uses of the isolated antigen binding protein in preventing, alleviating and/or treating tumor.
    Type: Application
    Filed: August 20, 2020
    Publication date: November 9, 2023
    Applicant: Harbour BioMed (Shanghai) Co., Ltd
    Inventors: Lei SHI, Xin GAN, Qianqian SHAN, Yiping RONG, Yun HE